We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Researchers have developed a hydrogel therapy that in early tests prevented SARS-Cov-2 from infecting cells without targeting specific receptors on the spike.